Healthtech startup Lifesigns raises funding from Healthcare Capital

Healtech startup Lifesigns has raised an undisclosed amount of funding from Healthcare Capital, the investment arm of the Kauvery Hospital Group.

The startup will use the investment primarily to advance its AI and predictive algorithm capabilities, further enhancing its proprietary patient monitoring platform.

What does Lifesigns do?

Founded in 2020, Lifesigns offers USFDA-approved hardware, software, dashboard, and AI integration, delivering proactive alerts and predictive insights across the patient journey—from ambulances to hospitals and home care.

“Our journey with Kauvery Hospital has been more than just a customer relationship—it has been a partnership in innovation. This investment from Healthcare Capital is a testament to the trust they place in our technology and its impact on healthcare outcomes,” said Hari Subramaniam, Founder and CEO of Lifesigns.

“With this funding, we aim to push the boundaries of AI-driven patient monitoring, empowering healthcare professionals with predictive tools that eliminate uncertainty and enable confident decision-making," Subramaniam added.

Planning for next fundraise

According to the company's statement, Lifesigns is also gearing up for its next funding round in the next couple of months, where it plans to unveil new tech products and market expansion initiatives.

The startup claims to have deployed its solutions across private and government hospitals in India, as well as in public health initiatives.

“As a healthcare provider, we understand the critical need for advanced monitoring solutions that enhance patient safety and ease the burden on healthcare professionals,” Dr Aravindan Selvaraj, Executive Director, Kauvery Hospital and Healthcare Capital.

“Lifesigns’ technology is a game-changer, and we are excited to support their mission in redefining patient monitoring with AI-powered predictive analytics.”